Literature DB >> 12374812

Activation of an unfolded protein response during differentiation of antibody-secreting B cells.

Jennifer N Gass1, Nicole M Gifford, Joseph W Brewer.   

Abstract

The unfolded protein response pathway (UPR) is believed to detect and compensate for excessive protein accumulation in the endoplasmic reticulum (ER). The UPR can be induced by pharmacological agents that perturb ER functions, but may also occur during cellular developmental processes such as the transition of B-lymphocytes into antibody-secreting plasma cells. Here we show that major UPR components are activated in B cells stimulated to secrete antibody. Increased expression of UPR targets including the ER chaperones BiP and GRP94 and the transcription factor XBP-1 initiates early in the differentiation program prior to up-regulated synthesis of Ig chains. Furthermore, these same kinetics are observed during differentiation for cleavage of the ER-localized ATF6alpha protein and splicing of XBP-1 mRNA to generate p50ATF6alpha and p54XBP-1, the two known UPR transcriptional activators. All of these UPR events reach maximal levels once Ig synthesis and secretion are markedly induced. Interestingly, these events are not accompanied by expression of CHOP, a transcription factor induced by ER stress agents commonly used to investigate the UPR. These results suggest that a physiological UPR elicited during differentiation of B-lymphocytes into high-rate secretory cells may be distinct from the UPR defined by agents that disrupt protein maturation in the ER.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12374812     DOI: 10.1074/jbc.M205011200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  119 in total

Review 1.  GRP94: An HSP90-like protein specialized for protein folding and quality control in the endoplasmic reticulum.

Authors:  Michal Marzec; Davide Eletto; Yair Argon
Journal:  Biochim Biophys Acta       Date:  2011-11-03

Review 2.  The unfolded protein response in lung disease.

Authors:  Stefan J Marcinak; David Ron
Journal:  Proc Am Thorac Soc       Date:  2010-11

3.  Stable binding of ATF6 to BiP in the endoplasmic reticulum stress response.

Authors:  Jingshi Shen; Erik L Snapp; Jennifer Lippincott-Schwartz; Ron Prywes
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

4.  Stable ribosome binding to the endoplasmic reticulum enables compartment-specific regulation of mRNA translation.

Authors:  Samuel B Stephens; Rebecca D Dodd; Joseph W Brewer; Patrick J Lager; Jack D Keene; Christopher V Nicchitta
Journal:  Mol Biol Cell       Date:  2005-10-12       Impact factor: 4.138

5.  XBP-1 is required for biogenesis of cellular secretory machinery of exocrine glands.

Authors:  Ann-Hwee Lee; Gerald C Chu; Neal N Iwakoshi; Laurie H Glimcher
Journal:  EMBO J       Date:  2005-12-15       Impact factor: 11.598

6.  Intrinsic capacities of molecular sensors of the unfolded protein response to sense alternate forms of endoplasmic reticulum stress.

Authors:  Jenny B DuRose; Arvin B Tam; Maho Niwa
Journal:  Mol Biol Cell       Date:  2006-05-03       Impact factor: 4.138

7.  The xbp-1 gene is essential for development in Drosophila.

Authors:  Sami Souid; Jean-Antoine Lepesant; Constantin Yanicostas
Journal:  Dev Genes Evol       Date:  2007-01-06       Impact factor: 0.900

8.  Transcription factor MIST1 in terminal differentiation of mouse and human plasma cells.

Authors:  Benjamin J Capoccia; Jochen K M Lennerz; Andrew J Bredemeyer; Jeffery M Klco; John L Frater; Jason C Mills
Journal:  Physiol Genomics       Date:  2010-11-23       Impact factor: 3.107

9.  The unfolded protein response of B-lymphocytes: PERK-independent development of antibody-secreting cells.

Authors:  Jennifer N Gass; Hao-Yuan Jiang; Ronald C Wek; Joseph W Brewer
Journal:  Mol Immunol       Date:  2007-09-05       Impact factor: 4.407

10.  CD28-B7 interaction modulates short- and long-lived plasma cell function.

Authors:  Modesta N Njau; Jin Hyang Kim; Craig P Chappell; Rajesh Ravindran; Leela Thomas; Bali Pulendran; Joshy Jacob
Journal:  J Immunol       Date:  2012-08-20       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.